Career development is a particularly important activity for translational research programs. By its verynature, translational research is multidisciplinary. Because of the depth of knowledge required of eachindividual discipline, our present educational structure seldom allows trainees to function in amultidisciplinary environment. This Career Development Awards Program is designed to provide theincentive and structure necessary to bring junior investigators into the multidisciplinary translational researcharena. The key to success of this endeavor is the availability and willingness of mentors throughout DF/HCCto meet the challenges of translational research. This Program will be led by Dr. Monica Bertagnolli,Program Director of the Feinberg Surgical Oncology Fellowship at Brigham and Women's Hospital and Co-Pi of the DF/HCC SPORE, and Dr. Robert Mayer, Vice-Chair for Academic Affairs at the Dana-FarberCancer Institute (DFCI) and Director of the DF/PCC Medical Oncology Fellowship. They are joined by acommittee including leaders in the fields of cancer therapeutics (Drs. Chabner and Schnipper), Gl cancersurgery (Drs. Warshaw and Zinner), tumor biology and genetics (Drs. Livingston, Kucherlapati, andPodolsky), cancer epidemiology (Dr. Willett), and women's health and health care disparities (Dr. Bigby).These outstanding senior mentors, representing BWH, MGH, DFCI, and BIDMC, will direct a program thatensure optimal selection, support, and oversight of the Gl SPORE Career Development Awards Program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
1P50CA127003-01
Application #
7248228
Study Section
Special Emphasis Panel (ZCA1-GRB-I (J1))
Project Start
2007-04-01
Project End
2012-03-31
Budget Start
2007-04-01
Budget End
2008-06-30
Support Year
1
Fiscal Year
2007
Total Cost
$196,052
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Katona, Bryson W; Yurgelun, Matthew B; Garber, Judy E et al. (2018) A counseling framework for moderate-penetrance colorectal cancer susceptibility genes. Genet Med 20:1324-1327
Jeon, Jihyoun; Du, Mengmeng; Schoen, Robert E et al. (2018) Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors. Gastroenterology 154:2152-2164.e19
Kosumi, Keisuke; Hamada, Tsuyoshi; Koh, Hideo et al. (2018) The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome. Am J Pathol 188:2839-2852
Aguirre, Andrew J (2018) Refining Classification of Pancreatic Cancer Subtypes to Improve Clinical Care. Gastroenterology 155:1689-1691
Wong, Gabrielle S; Zhou, Jin; Liu, Jie Bin et al. (2018) Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition. Nat Med 24:968-977
Wang, Xiaoliang; Chan, Andrew T; Slattery, Martha L et al. (2018) Influence of Smoking, Body Mass Index, and Other Factors on the Preventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Colorectal Cancer Risk. Cancer Res 78:4790-4799
Liu, Li; Tabung, Fred K; Zhang, Xuehong et al. (2018) Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum. Clin Gastroenterol Hepatol 16:1622-1631.e3
Aguirre, Andrew J; Hahn, William C (2018) Synthetic Lethal Vulnerabilities in KRAS-Mutant Cancers. Cold Spring Harb Perspect Med 8:
Yang, Wanshui; Liu, Li; Masugi, Yohei et al. (2018) Calcium intake and risk of colorectal cancer according to expression status of calcium-sensing receptor (CASR). Gut 67:1475-1483
Stachler, Matthew D; Camarda, Nicholas D; Deitrick, Christopher et al. (2018) Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma. Gastroenterology 155:156-167

Showing the most recent 10 out of 590 publications